MAPK8 and malignant colon neoplasm: JNK has been reported in colon and other cancer cells to sustain multidrug resistance (MDR), and inhibition of JNK enhanced the apoptosis of colon cancer cells treated with chemotherapy agents such as nocodazole, camptothecin and 5-FU [17–19].